Article Details
Retrieved on: 2024-02-27 08:17:24
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights AstraZeneca PLC's unusual options trading, its financials including dividends, various ratios like P/E and debt-to-equity, and analysts' ratings, indicating investor interest and potential for investment in medical research, particularly in the context of the COVID-19 vaccine developed with Oxford.
Article found on: www.marketbeat.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here